← All trials
NCT02980250
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2015
- Primary completion
- May 1, 2017
- Completion date
- Jun 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Southern Medical UniversityLead sponsor
- Maternal and Child Health Hospital of FoshanCollaborator
- Southern Medical UniversityReponsible party - principal investigator
- Guangdong Provincial Maternal and Child Health HospitalCollaborator
- Shen-Zhen City Maternity and Child Healthcare HospitalCollaborator
- Guangzhou Panyu Central HospitalCollaborator
- Southern Medical UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.